Twentyeight Health partners with Healthify to expand its reproductive and sexual health services

Targeting the population that’s most underserved with new treatment options has been part of the mission for Twentyeight Health since its launch. Now a new partnership with the venture-backed startup Healthify means that the company will be able to expand its reach. 

Healthify works with managed-care organizations and case workers to integrate social determinants of health into the healthcare system.

Social factors have a significant role to play in patient outcomes, according to new research, and both Twentyeight Health and Healthify are trying to do their part to ensure that access to care becomes less of an issue.

Twentyeight Health sells and delivers birth control pills, patches, rings, shots and emergency contraception prescriptions at a low cost — or covered by insurance, including Medicaid.

Through the Healthify integration, the company will be able to offer its services through health plans and providers that use Healthify to determine social factors that may influence treatment, the companies said.

“This partnership comes at a time when many women in vulnerable communities are in need of prescription delivery or virtual healthcare services due to COVID-19,” said Amy Fan, co-founder of Twentyeight Health. “By working with Healthify, we can strengthen our efforts to ensure that all women who want birth control are able to access it.”

Since its launch two years ago, Twentyeight Health is now operating in six states, including Florida, Maryland, New Jersey, New York, North Carolina and Pennsylvania.

“Together, we can expand Twentyeight Health’s impact by offering their services to help individuals receive the low- or no- cost birth control that is right for them,” said Manik Bhat, founder and chief executive officer of Healthify.

To date, Healthify has raised $25.5 million from investors, including Primary Venture Partners and BlueCross Blue Shield Venture Partners. Twentyeight Health recently announced a $5 million early-stage round of funding and is backed by investors, including Third Prime and Town Hall Ventures.